Found's advertised $99/month figure requires insurance; its cash-pay compounded semaglutide costs $289 month-to-month or $169/month prepaid annually.

Found's advertised rates are prepaid annual commitments, not promotional first-month prices. The $169 semaglutide figure requires $2,028 upfront; the month-to-month rate is $289. We show the true recurring cost over twelve months.

Found offers two pricing models—insurance-supported plans and cash-pay subscriptions—with rates ranging from a 12-month prepaid equivalent of $99/month to $359/month billed monthly. We break down each track's real recurring costs, medication coverage, and what the insurance option actually covers.

If you're moving from another GLP-1 provider, Found offers insurance-accepted options and a cancellation-friendly structure. PlexusDx delivers lower cash prices, oral formats, and month-to-month flexibility. Here's how the economics and features compare for transfer patients.

Found offers 12-month prepaid plans and an insurance track that can serve long-term maintenance well. Whether it beats cash-pay alternatives depends on your coverage and commitment horizon. We compare Found's maintenance fit against PlexusDx cash programs.

Found charges $289/month for compounded semaglutide and $359/month for tirzepatide on month-to-month cash plans. Their insurance track and 24/7 care team app deliver value for committed users, but PlexusDx costs $100–$70/month less on comparable plans.